Phase I study of intravenous (IV) milataxel in adult patients with advanced malignant tumors.

被引：0
|
作者：
Bourbouloux, E.
Campone, M.
Vermorken, J. B.
Martin, M.
Sessa, C.
Perotti, A.
机构：
[1] Univ Antwerp Hosp, Antwerp, Belgium
[2] Hosp Clin Univ San Carlos, Madrid, Spain
[3] Osped San Giovani, Bellinzona, Switzerland
[4] Ist Nazl Tumori, I-20133 Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：88S / 88S
页数：1
相关论文
共 50 条
  • [21] Phase I study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors.
    Xu, B.
    Shen, L.
    Ye, D.
    Jappe, A.
    Wang, H.
    Yuan, R.
    Wu, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Phase I study of olaparib in combination with carboplatin and/or paclitaxel in patients with advanced solid tumors.
    van der Noll, Ruud
    Ang, Joo Ern
    Jager, Agnes
    Marchetti, Serena
    Mergui-Roelvink, Marja
    De Bono, Johann Sebastian
    Lolkema, Martijn
    Brunetto, Andre
    Arkenau, Hendrik-Tobias
    De Jonge, Maja J.
    van der Biessen, Diane
    Tchakov, Ilian
    Bowen, Karin
    Schellens, Jan H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [23] A phase I study evaluating COM701 in patients with advanced solid tumors.
    Rasco, Drew W.
    Vaena, Daniel A.
    Sullivan, Ryan J.
    Luke, Jason J.
    ElNaggar, Adam
    Hunter, John
    Adewoye, Adeboye H.
    Olweny, Judy
    Patnaik, Amita
    Hamilton, Erika Paige
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [24] A phase I clinical study of biweekly pemetrexed and gemcitabine in patients with advanced solid tumors.
    Dudek, A
    Larson, T
    Mellskog, CE
    Bloss, LP
    Obasaju, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 162S - 162S
  • [25] A phase I study of SB-408075 administered as a single intravenous infusion once weekly in patients with advanced solid tumors.
    Helft, PR
    Schilsky, RL
    Kindler, HL
    Bertucci, D
    Dewitte, MH
    Martino, HK
    Friedman, CJ
    Erickson, JC
    Lambert, JM
    Ratain, J
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3786S - 3786S
  • [26] Phase I pharmacokinetic (PK) and safety study of intravenous (IV) Cl-1033 in patients with advanced solid tumors
    Simon, GR
    Olson, S
    Garrett, CR
    Eiseman, I
    Langevin, M
    Mahany, JJ
    Sullivan, DM
    Schlicht, MG
    Lush, R
    Lanehan, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 209S - 209S
  • [27] A phase I trial of sarcosinamide nitrosourea in adult patients with solid tumors.
    Puchalski, TA
    Eder, JP
    Ryan, DP
    Clark, JW
    Castellana, W
    Garcia-Carbonero, R
    Kufe, DW
    Supko, JG
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3709S - 3709S
  • [28] Phase I trial of irinotecan and epirubicin in patients with advanced solid tumors.
    Gold, PJ
    Refice, S
    West, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 164S - 164S
  • [29] A phase I study of MEDI6383, an OX40 agonist, in adult patients with select advanced solid tumors.
    Bauer, Todd Michael
    Chae, Young Kwang
    Patel, Sandip
    D'Angelo, Sandra P.
    Blumenschein, George R.
    Norton, Jonathan
    Pound, Carol
    Lanasa, Mark C.
    Curti, Brendan D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] A phase I study of PT-112 in advanced solid tumors.
    Karp, Daniel D.
    Camidge, D. Ross
    Bryce, Alan Haruo
    Jimeno, Jose
    Infante, Jeffrey R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345